ClinicalTrials.Veeva

Menu

Study Evaluating the Parent-child Relationship During the Hospitalisation of a Parent in Long-term Protective Isolation (VIK-e2)

L

Léon Bérard Center

Status

Completed

Conditions

Cancer

Treatments

Other: Telepresence robot installed at child's home during parent's hospitalisation

Study type

Observational

Funder types

Other

Identifiers

NCT04856332
ET19-193 - VIK-e2

Details and patient eligibility

About

The intensive treatments of certain cancers and haemopathies require the implementation of a protective isolation from external micro-organisms for a period of several weeks. This isolation implies a limitation of visitors and sometimes prohibits access to young children. This raises questions concerning the maintenance of family links, and in particular the parent-child relationship as well as the psychological and emotional isolation of hospitalised patients and the resulting psychological effects.

Full description

Telepresence robots are increasingly used as a means of remote communications, especially for teleconsultations and/or access to various public services (cultural events, education, etc.). In the context of long-term hospitalisation, they can be used for various purposes, such as access to cultural events, university activities, contact with patient's home and maintenance of family links. Some studies have analyzed the use of these robots and their effects in academic settings or the suitability of their use with elderly populations for continuing care.

To our knowledge, no study has evaluated the interest for the parent-child relationship of the use of a telepresence robot during the hospitalisation in protective isolation for a long period of a patient with young child(ren).

We propose to conduct this observational, multi-center prospective study aiming at evaluating the parent-child relationship following the setting up of a mobile telepresence robot for patients with children aged 15 years or less and hospitalised in long-term protective isolation.

Enrollment

31 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age≥ 18
  • Patient with at least one child aged 15 or under
  • Pathology requiring a prolonged hospitalization in protective isolation
  • Consent dated and signed

Exclusion criteria

  • Impaired cognitive functions
  • Performance Status -Eastern Cooperative Oncology Group (PS-ECOG) = 4
  • Difficulties in speaking and understanding French
  • Patient under guardianship or curatorship

Trial contacts and locations

3

Loading...

Central trial contact

GUILLERMIN Yann, MD; METZGER Séverine

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems